What's new?

Added 11 hours ago Drug news

FDA grants accelerated approval for Tazervik to treat metastatic or locally advanced epithelioid sarcoma .- Epizyme Inc.

-Epizyme, Inc. announced that the FDA has granted accelerated approval of Tazverik (tazemetostat) for the treatment of adults and pediatric...

Added 11 hours ago Drug news

New indication approved for Infinity Deep Brain Stimulation (DBS) system to improve symptoms of Parkinson's disease.- Abbott

Abbott has announced it received approval from the FDA for a new, expanded indication for the company's Infinity Deep Brain...

Added 11 hours ago Drug news

Phase III AKP01 study of Akvano shows efficacy in plaque psoriasis.- Lipidor

Lipidor AB reports positive topline results of its AKP01 Phase III clinical study, using Akvano (calcipotriol spray) against mild to...

Added 11 hours ago Drug news

Tecentriq fails in Phase III IMvigor010 study as an adjuvant (after surgery) monotherapy compared to observation in people with muscle-invasive urothelial cancer .-Genentech/Roche

Roche announced that the Phase III IMvigor010 study evaluating Tecentriq (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not...

Added 1 day ago Drug news

Phase III OPTIC clinical trial evaluating Tepezza for thyroid eye disease is published in NEJM.- Horizon Therapeutics

Horizon Therapeutics plc announced that The New England Journal of Medicine has published comprehensive results of the Phase III OPTIC...